ArticleScientific reports2025
A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
16 authors.
Funding
Abstract
In the growing field of electrophysiology, cardiac ablation either via heating or freezing target tissues using catheters, induces localised scarring to block or destroy defective electrical pathways in the heart. To test equipment and ablation settings, studies have resorted to ex-vivo and in-vivo models including pigs, dogs, and chickens. The use of animal tissue presents ethical and logistical complications and introduces variability between samples and between studies. In a scientific community faced with progressively more stringent ethics and regulations on animal testing, a more practical and ethical alternative should be established. To meet this need, multiple studies have proposed tissue-mimicking materials. However, either toxicity or poorly matched physical properties, prevented these materials from reaching widespread application. Furthermore, no material has yet been identified to test both cryoablation and radiofrequency ablation. Here, we present a novel thermochromic alginate hydrogel material that can simulate ablation lesions for both radiofrequency ablation and cryoablation. This material could find direct applications in electrophysiology, but adapted mixtures could also be used to recreate other tissues for different simulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.